Spectros Medical Devices
Spectros Medical Devices is a privately-held medical device company that develops the T-Stat Tissue Oximeter, a noninvasive Visible Light Spectroscopy monitor of tissue perfusion. It serves reconstructive microsurgeons, oncology centers, gastroenterologists, and critical care providers globally.
- Company typePrivate
- Founded2001
- HeadquartersHouston, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Spectros Medical Devices does
Spectros Medical Devices Inc., legally Spectros Corporation, is a privately-held medical device company headquartered at 2211 Norfolk Street in Houston, Texas (with legal domicile in California), founded by David Benaron, MD (Harvard Medical School, MIT-trained, Stanford ICU physician). The company was acquired in 2017 by AAI (Advanced Ambulatory, Inc.), a specialty distributor in the Plastic & Reconstructive Surgery market founded by current CEO Rob Pupelis; Spectros now operates as a subsidiary of AAI. Its core technology is Visible Light Spectroscopy (VLS), which uses broad-band white-LED illumination to noninvasively measure tissue oxygen saturation (StO2%) and hemoglobin concentration, with claimed advantages over pulse oximetry (sensitive to ischemia) and NIRS-based devices (tighter normal ranges; correlation with invasive SvO2).
The product portfolio centers on the T-Stat Tissue Oximeter and its 2020 redesign, T-Stat 2.0, which added battery backup, WiFi and cellular connectivity, and an enhanced user interface. T-Stat Sensors are consumable/disposable components, and OnCall is a HIPAA-compliant web-based companion application that provides surgeons with remote, real-time and historical access to StO2% and hemoglobin data. Founder David Benaron holds over 30 US and international patents covering Spectros' biomedical devices, methods, and technology.
Commercial operations are enterprise field-sales led, with sales targeting hospital systems, cancer centers, and reconstructive microsurgery programs; AAI serves as the primary distribution channel for the Plastic & Reconstructive Surgery market. Revenue mechanics combine hardware sales (T-Stat devices and sensors) with what appears to be subscription or license revenue from the OnCall remote-monitoring software. The primary customer segment is reconstructive microsurgery (free flap monitoring), with secondary verticals in endoscopy/gastroenterology (mucosal perfusion, chronic mesenteric ischemia), critical care / pediatric cardiac, and neonatology. Named end-users include MD Anderson Cancer Center, UCSF, Northwestern Memorial Hospital, PRMA Plastic Surgery, University of Chicago, and Maastricht University / IEO Milan. Pricing is not publicly disclosed; the company uses multi-year procurement contracts with quotes handled via direct contact or through AAI. The company markets actively through clinical study publications, specialty conferences (London Breast Meeting, WSRM), content marketing, and educational partnerships, and has been recognized with the 2021 Health Care Insights Company of the Year and 2022 DotCom Magazine Impact Company of the Year awards.
Spectros Medical Devices firmographics
Firmographics- Name
- Spectros Medical Devices
- Legal name
- Spectros Corporation
- Website
- https://spectros.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Spectros Medical Devices is a privately-held medical device company that develops the T-Stat Tissue Oximeter, a noninvasive Visible Light Spectroscopy monitor of tissue perfusion. It serves reconstructive microsurgeons, oncology centers, gastroenterologists, and critical care providers globally.
- Ownership category
- akta.pro rank
Spectros Medical Devices industry classification
Industry- Product category
- Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)
Keywords
Where Spectros Medical Devices is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Spectros Medical Devices business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- T-Stat Tissue Oximeter Hardware: Sale of medical monitoring devices and associated sensors for tissue oximetry in surgical settings.
- OnCall Remote Monitoring Software: Web-based remote access application for real-time and historical patient monitoring data, likely sold as subscription or license.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Contact for pricing - demo and quote requests |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Spectros Medical Devices product offering
Product offeringCore offering
Spectros Medical Devices develops and manufactures the T-Stat Tissue Oximeter, a noninvasive patient monitor that uses Visible Light Spectroscopy (VLS) with white LEDs to measure tissue perfusion (StO2%) and hemoglobin concentration for surgical and critical care settings. The portfolio also includes the OnCall web-based remote monitoring application that provides real-time and historical data access to surgeons.
Product overview
Spectros Medical Devices offers a focused portfolio of medical devices centered on the T-Stat Tissue Oximeter, a noninvasive patient monitor that uses Visible Light Spectroscopy to measure tissue perfusion and hemoglobin concentration. The product line includes the T-Stat 2.0 hardware device, proprietary T-Stat Sensors, and OnCall, a companion web-based remote monitoring application. The company specializes in optical sensing technology for free flap monitoring, reconstructive microsurgery, endoscopy, and critical care applications.
Differentiator
Problem solved
Functional benefit
Brands
- T-Stat: Tissue oximeter device that measures tissue perfusion using Visible Light Spectroscopy for monitoring free flap surgeries and tissue health
- OnCall
- T-Stat 2.0
Products and services
- T-Stat Tissue Oximeter The T-Stat Tissue Oximeter is a noninvasive patient monitor that measures tissue perfusion using Visible Light Spectroscopy (VLS) with broad band analysis via white LEDs. It provides reproducible StO2% and hemoglobin concentration readings for monitoring tissue health in surgical and critical care settings. It is used by reconstructive microsurgeons, surgical oncologists, and critical care physicians.
- OnCall Remote Access OnCall is a HIPAA-compliant web-based application that provides remote access to real-time and historical T-Stat data (StO2% and hemoglobin readings), enabling surgeons to monitor patients from anywhere with cellular or WiFi connectivity.
Quantifiable outcome
- Nearly 100% flap success rate reported by PRMA Plastic Surgery
- +2 more outcomes
Companies that use Spectros Medical Devices
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Spectros Medical Devices technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Spectros Medical Devices partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Viewpoint Educational ProgramcoreSpectros Medical Devices featured by industry experts on Viewpoint educational program, highlighting the latest innovations and advancements of T-Stat in patient monitoring. Represents strategic educational partnership to showcase technology to healthcare professionals.
- AAI (Advanced Ambulatory Inc.)coreAAI serves as the primary distribution partner for Spectros in the Plastic & Reconstructive Surgery market. Founded by current CEO Rob Pupelis in 2002, AAI became a leading distributor in this space before the acquisition of Spectros in 2017. AAI handles product upgrades, demonstrations, and support for this key market segment.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Spectros Medical Devices competitors and assessment
Company assessmentBroad incumbents
- Nihon Kohden: Established patient monitoring and neurology device manufacturer with global hospital footprint; competes for multi-parameter monitoring budgets that include oxygen saturation modalities.
- Edwards Lifesciences: Incumbent in hemodynamic and tissue perfusion monitoring (e.g., FloTrac, FORE-SIGHT cerebral oximetry) with overlapping interest in tissue oxygen saturation monitoring in surgical and critical care settings.
- Masimo: Broad incumbent in pulse oximetry and patient monitoring with strong hospital channel presence; competes indirectly through its rainbow SET and SedLine monitoring platforms and could expand into tissue oximetry.
- GE HealthCare: Broad incumbent in patient monitoring, including operating room and critical care monitoring ecosystems; a competitor in hospital procurement decisions for tissue and oxygen monitoring.
- Medtronic: Global medical device incumbent with extensive patient monitoring and critical care portfolio; represents a large installed-base competitor for hospital monitoring procurement decisions.
- Philips: Major patient monitoring and clinical informatics provider with comprehensive ICU and OR monitoring suites; an indirect competitor for tissue and oxygen monitoring integration.
Direct peers
- Nonin Medical: Specialist in pulse oximetry and NIRS-based physiological monitoring sensors used in clinical and remote patient monitoring; competes with Spectros in tissue oxygen measurement applications.
- ViOptix: Direct peer in tissue oximetry for free flap and reconstructive surgery monitoring; uses near-infrared spectroscopy for perfusion assessment in the same surgical use cases as Spectros's T-Stat.
Emerging players
- Moor Instruments: Specialist in laser Doppler perfusion imaging and tissue blood flow monitoring; offers complementary perfusion assessment technology relevant to flap and microcirculation monitoring use cases.
Others
- Hamamatsu Photonics: Optical sensor and light-source technology provider with deep capabilities in spectroscopy and photonics; relevant as both a potential enabler of and adjacent competitor in clinical optical sensing.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Spectros Medical Devices social profiles
Digital presenceSpectros Medical Devices compliance and trust
Trust signalCompliance1 record
Spectros Medical Devices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Spectros Medical Devices leadership team
Management profileNumber of profiles
Profiles3 records
Spectros Medical Devices funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Spectros Medical Devices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Spectros Medical Devices
What does Spectros Medical Devices do?
Spectros Medical Devices develops and manufactures the T-Stat Tissue Oximeter, a noninvasive patient monitor that uses Visible Light Spectroscopy (VLS) with white LEDs to measure tissue perfusion (StO2%) and hemoglobin concentration for surgical and critical care settings. The portfolio also includes the OnCall web-based remote monitoring application that provides real-time and historical data access to surgeons.
Is Spectros Medical Devices a public or private company?
Spectros Medical Devices is a private company. It is classified as corporate owned and is currently operating.
When was Spectros Medical Devices founded?
Spectros Medical Devices was founded in 2001. It employs 11 to 50 people.
Where is Spectros Medical Devices based?
Spectros Medical Devices is headquartered in Houston, United States, in the North America region.
How does Spectros Medical Devices make money?
Two revenue lines are on record. T-Stat Tissue Oximeter Hardware is the primary driver. The others are onCall Remote Monitoring Software.
Who are Spectros Medical Devices's main competitors?
Broad incumbents on record are Nihon Kohden, Edwards Lifesciences, Masimo, GE HealthCare, Medtronic and Philips. Direct peers are Nonin Medical and ViOptix. Moor Instruments is listed as an emerging player. Hamamatsu Photonics is listed as an others.
Does Spectros Medical Devices have an API?
No public API is recorded for Spectros Medical Devices.
What industry is Spectros Medical Devices in?
Spectros Medical Devices's product category is Medical Devices. Its primary akta.pro industry code is HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry). Its NAICS code is 334510 and its SIC code is 3845.